Navigation Links
NWBT Highlights Cost Effectiveness of DCVax® in View of Recent Immunotherapy Pricing Concerns
Date:8/10/2011

t a few weeks.

Another important factor in the cost effectiveness of DCVax® is its simplicity and ease of administration.  DCVax® is delivered as a small intra-dermal injection under the skin, similar to a flu shot.  As such, it can be administered in any physician's office or clinic.  There is no lengthy intravenous infusion, with the attendant patient discomfort, cost and need for a specialty infusion center.  In contrast, Dendreon's Provenge is delivered by intravenous infusion.

The cost effectiveness of NWBT's DCVax® is enhanced by the fact that DCVax® is targeting a portion of the prostate cancer market that is 4 times the size of the market segment that Dendreon's Provenge is currently targeting.  The late stage prostate cancer market breaks down into two groups of patients:  those who do not yet have metastases (i.e., spread of the cancer beyond the prostate), who constitute 80-85% of the market, and those who do already have metastases, who constitute 15-20% of the market.  Dendreon's Provenge is approved for and targeted to the patients with metastases (i.e., the 15-20% portion of the market).  In contrast, NWBT's prior Phase I/II trial treated both groups of patients, and NWBT's 612-patient Phase III trial design is focused on the much bigger market:  patients without metastases (i.e., 80-85% of the market).

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis.  The Company has a broad platform technology for dendritic cell-based vaccines.  The Company's lead clinical trial, with a growing number of sites, is a 240-patient, Phase II trial in newly diagnosed Glioblastoma multiforme ("GBM"
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
2. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
3. Isis Reports Financial Results and Highlights for Second Quarter 2011
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Thomas Publishing Expands Brand Information and Highlights Its Career Center on a New Company Website
6. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
7. Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
8. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
9. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
10. Isis Reports Financial Results and Highlights for First Quarter 2011
11. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  It may seem like an ... for breast cancer. But these were two of the most ... th Annual Meeting & Expo that just convened in ... saying this focus by some of the top internal medicine ... obsession with new research that can not only save lives, ...
(Date:6/18/2013)... 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit Breakers announced ... Module. The X3130, integrated with E-T-A,s double-pole ... appliance inlet module, rocker switch and resettable overcurrent ... allows design engineers to streamline the number of ... by 66 percent - and reduce the overall ...
(Date:6/18/2013)... N.Y. , June 18, 2013  Millennium ... it has entered into an exclusive 25-year Supply ... regions with eWellness Corporation ("EWC") for its Distance ... easy to use physical therapy program is a ... and cardiovascular disease," said Chris Amandola , ...
Breaking Medicine Technology:"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Three-in-One X3130 Appliance Inlet Module 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3
... 17, 2011 DJO Incorporated ("DJO" ... for musculoskeletal health, vascular health and pain management, today announced ... Executive Officer ("CEO"). Mr. Cross will transition ... the DJO Board of Directors between now and June 30, ...
... CarePoint Partners (CarePoint) announced that it has completed the ... provides home infusion and specialty infusion in conjunction with ...  With this acquisition and the acquisition of a Dallas-Fort ... Partners is now a leader of home infusion services ...
Cached Medicine Technology:DJO Incorporated Announces Planned Transition of President and CEO Les Cross 2DJO Incorporated Announces Planned Transition of President and CEO Les Cross 3CarePoint Partners Acquires Houston-Based ivA Lifetec, Further Expanding Network of Regional Home Infusion and Specialty Pharmacy Providers 2
(Date:6/19/2013)... “We are proud to introduce the Pond Defender. ... in the U.S.,” says Shaun Johnson, Retail & Mass Merchant ... solution to a very expensive problem, considering customers pay hundreds ... adds. , Each package of Pond Defender features twelve ... of any water garden or pond. The discs create a ...
(Date:6/19/2013)... 19, 2013 The US Food and Drug ... ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™. , The ... February 2013. The FDA announced the approval of the MemoryShape™ ... primary augmentations in women 22 years old or ... , The FDA’s approval comes after six years of ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The producers of ... dates for Phoenix, Arizona. The city is located in ... Sun”. It has shed its frontier image and become an ... It is the fifth-largest city in the United States with ... industries. It offers residents a low cost-of-living, friendly business environment ...
(Date:6/19/2013)... For years, Alzheimer,s researchers have focused on two ... Alzheimer,s and may contribute to the disease: plaques made ... protein, called tau. , But for the first time, ... two proteins independently, but at the interaction of the ... tissue of post-mortem Alzheimer,s patients and in mouse brains ...
(Date:6/19/2013)... is many fold higher in persons over 65 years ... how best to treat these older cancer patients. Furthermore, ... trials, those elderly patients who are eventually included are ... patient population is not well represented in clinical trials. ... now starting a new phase 2 trial in precisely ...
Breaking Medicine News(10 mins):Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2Health News:Viewpoints TV Announces June Air Dates for Phoenix, AZ 2Health News:New Alzheimer's research suggests possible cause: The interaction of proteins in the brain 2Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2
... in U.S., Canada, study says , FRIDAY, April 16 ... places across the United States and Canada could save ... die of cardiac arrest each year, researchers report. , ... in more limited setting, such as casinos or airports, ...
... Inserting new valve within the valve might help high-risk ... -- If an artificial heart valve derived from a ... implanting a mechanical valve inside the artificial valve could ... and opened, the new valve opens and functions similarly ...
... brain lesions developed in patients taking Lipitor than placebo, ... Cholesterol-lowering statin drugs may slow the progression of multiple ... 81 patients with early-stage MS randomly selected to take ... a placebo. After 12 months of treatment, 55.3 percent ...
... Cardiovascular disease appears to be a major risk factor ... -- People with atrial fibrillation, a form of abnormal heart ... Alzheimer,s disease, a new study finds. , The presence of ... especially among younger patients in the group studied, meaning under ...
... Mo. For seniors, dancing isn,t just for fun; ... by University of Missouri researchers found that participation in ... adults. Improved functionality among seniors can decrease their risk ... as dance-based therapy have the potential to significantly reduce ...
... ... ... Researchers at Drexel University College of Medicine have discovered that a certain type ... critical for cancer growth and movement. When researchers reduced and normalized the levels of this ...
Cached Medicine News:Health News:Public Defibrillators Save Lives 2Health News:Public Defibrillators Save Lives 3Health News:Cholesterol Drugs May Slow MS 2Health News:Abnormal Heart Rhythm Linked to Alzheimer's 2Health News:Abnormal Heart Rhythm Linked to Alzheimer's 3Health News:Dance therapy improves seniors' gait, balance, researcher finds 2Health News:Scientists Report Key Finding in Breast Cancer Research 2Health News:Scientists Report Key Finding in Breast Cancer Research 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: